Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Financial results entities : Sanofi save search
Innate Pharma Announces Conference Call and Webcast for Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 07:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
NVO | News | $125.705 -2.28% 1.3M
|
Health Technology
|
| O: 2.33%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
IPHA | $2.37 170
|
Health Technology
|
| O: 1.51%
H: 2.38%
C: 2.08%
financial results conference results pharma
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
Published: 2022-03-16 (Crawled : 13:30) - biospace.com/
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | News | $88.15 -0.38% 96K
|
Health Technology
|
| O: 1.63%
H: 11.55%
C: 11.21%
financial results report results tiona
Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-15 (Crawled : 14:30) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -3.03%
H: 3.21%
C: 3.21%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: 0.0%
COGT | $6.96 180K
|
Health Technology
|
| O: 0.38%
H: 6.38%
C: 3.94%
financial results bioscience results
Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-09 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
BSX | $73.4 6.39% 6.4M
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
LYRA | $5.245 0.67% 78K
|
Health Technology
|
| O: -8.93%
H: 1.79%
C: -2.63%
BIIB | $202.7 4.93% 1.6M
|
Health Technology
|
| O: 2.65%
H: 1.72%
C: -1.88%
financial results therapeutics report results
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -4.06%
H: 0.0%
C: 0.0%
SGMO | News | $0.497 -4.59% 400K
|
Health Technology
|
| O: -2.04%
H: 0.0%
C: 0.0%
financial results therapeutics report results
Kymera Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides a Business Update
Published: 2022-02-24 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -4.06%
H: 0.0%
C: 0.0%
KYMR | $35.3 -1.15% 67K
|
Health Technology
|
| O: -2.56%
H: 13.17%
C: 12.27%
financial results ces therapeutics results
BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates
Published: 2022-02-23 (Crawled : 22:00) - investors.biomarin.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -4.06%
H: 0.0%
C: 0.0%
BMRN | $92.16 0.11% 310K
|
Health Technology
|
| O: -12.72%
H: 9.46%
C: 7.4%
financial results ces results
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Period Activity
Published: 2022-02-10 (Crawled : 13:30) - biospace.com/
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
IONS | $42.1 0.62% 290K
|
Health Technology
|
| O: 0.7%
H: 3.82%
C: 0.78%
ALNY | $144.215 -1.27% 110K
|
Health Technology
|
| O: -0.66%
H: 6.03%
C: 1.83%
als financial results report results
Ligand to Report Fourth Quarter Financial Results on February 17
Published: 2022-02-09 (Crawled : 20:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 2.73%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
LGND | $70.39 0.72% 25K
|
Health Technology
|
| O: 1.07%
H: 1.67%
C: 0.37%
financial results report results
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
Published: 2022-02-03 (Crawled : 14:30) - globenewswire.com
BMY | $48.76 -0.47% 3.9M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
REPL | $6.27 -2.34% 110K
|
Health Technology
|
| O: -0.33%
H: 4.15%
C: -0.38%
financial results report results
Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results
Published: 2022-02-03 (Crawled : 13:00) - biospace.com/
MRK | $126.28 -0.47% 1.3M
|
Health Technology
|
| O: -0.27%
H: 0.18%
C: -3.23%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
financial results ces results
Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinical Studies
Published: 2021-11-11 (Crawled : 14:15) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
|
| O: -2.91%
H: 0.0%
C: -8.51%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
financial results results insulin syndros
INOVIO Reports Third Quarter 2021 Financial Results
Published: 2021-11-09 (Crawled : 22:00) - inovio.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: -0.01%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.66%
H: 0.25%
C: -0.89%
INO | $10.185 -1.78% 110K
|
Health Technology
|
| O: 0.86%
H: 6.18%
C: 0.13%
financial results results
Acerus Reports Fiscal Third Quarter Financial Results
Published: 2021-11-09 (Crawled : 13:00) - globenewswire.com
FNCTF | News | $11.16 130
|
Communications
|
| O: 0.66%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
financial results results
BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update
Published: 2021-11-09 (Crawled : 12:15) - biospace.com/
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
BNTX | News | $88.15 -0.38% 96K
|
Health Technology
|
| O: 8.24%
H: 0.53%
C: -10.05%
financial results results
Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights
Published: 2021-11-08 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
GILD | $67.03 2.4M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
MTNB | $0.182 0.27% 80K
|
Health Technology
|
| O: -2.78%
H: 2.86%
C: -3.81%
biopharma financial results results
Sangamo Therapeutics Reports Recent Business and Clinical Highlights and Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SGMO | News | $0.497 -4.59% 400K
|
Health Technology
|
| O: 7.39%
H: 0.0%
C: 0.0%
financial results results
Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
Published: 2021-11-04 (Crawled : 01:00) - biospace.com/
VSTM | $9.31 -3.12% 29K
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
financial results results
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021
Published: 2021-11-04 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
RLAY | $6.0 1.7% 520K
|
Health Technology
|
| O: 0.03%
H: 1.35%
C: -2.39%
CLLS | News | $2.53 -3.42% 24K
|
Health Technology
|
| O: -5.54%
H: 7.67%
C: 5.43%
financial results results
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
BMY | $48.76 -0.47% 3.9M
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
REPL | $6.27 -2.34% 110K
|
Health Technology
|
| O: 4.09%
H: 2.47%
C: 0.85%
financial results results
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
RILY | $27.91 28.5% 8.9M
|
Finance
WHLM | $6.43 26.58% 580K
|
Commercial Services
Your saved searches
Save your searches and get alerts when important news are released.